Pyxis Oncology PYXS
NASDAQ PYXS
$1.76 -0.08 (-4.35%)
At close: Oct 21, 2026 · 4:00 PM EDT

Pyxis Oncology (PYXS) Receivables (2024 - 2025)

Updated

Pyxis Oncology's Receivables was $3 million in Q2 2025.

Analysis

Pyxis Oncology (PYXS) Receivables (2024 - 2025) Analysis & Trends

  • The Q2 2025 figure marks the highest quarterly Receivables since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 13.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 12.49 Bn
10 Pyxis Oncology 112.79 Mn -152.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 3.00 Mn
Mar 31, 2024 8.00 Mn
API Access

Pyxis Oncology Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=PYXS&period=max&api_key=YOUR_API_KEY